Chemoinformaics analysis of 3-Acetoxyamorpha-4,7(11)-dien-8-one
| Molecular Weight | 276.376 | nRot | 1 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 14 |
| Exact Molecular Weight | 276.173 | nRing | 2 |
| Solubility: LogS | -3.046 | nHRing | 0 |
| Solubility: LogP | 3.132 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.799 |
| nHD | 0 | BPOL | 27.549 |
| QED | 0.418 |
| Synth | 4.34 |
| Natural Product Likeliness | 2.238 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.95 |
| Pgp-sub | 0.077 |
| HIA | 0.08 |
| CACO-2 | -4.56 |
| MDCK | 0.0000153 |
| BBB | 0.727 |
| PPB | 0.920909 |
| VDSS | 1.579 |
| FU | 0.085076 |
| CYP1A2-inh | 0.173 |
| CYP1A2-sub | 0.146 |
| CYP2c19-inh | 0.318 |
| CYP2c19-sub | 0.899 |
| CYP2c9-inh | 0.305 |
| CYP2c9-sub | 0.078 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.178 |
| CYP3a4-inh | 0.503 |
| CYP3a4-sub | 0.637 |
| CL | 7.725 |
| T12 | 0.274 |
| hERG | 0.016 |
| Ames | 0.103 |
| ROA | 0.259 |
| SkinSen | 0.091 |
| Carcinogencity | 0.101 |
| EI | 0.04 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.685788 |